麻豆传媒

Kristen Monaco

Kristen Monaco

Authors >

Kristen Monaco

Kristen Monaco is a senior staff writer at 麻豆传媒, focusing on endocrinology, psychiatry, and nephrology medical news. Based out of the New York City office, she has worked at the company since 2015, originally having started off in the video production department. After her transition to writing, she managed a long-standing partnership newsletter with the American Association of Clinical Endocrinologists and was the 2017 recipient of the North American Menopause Society鈥檚 media award. She鈥檚 also a co-producer of 麻豆传媒鈥檚 medical storyteller podcast, Anamnesis. She holds a bachelor鈥檚 degree in psychology and a double minor in anthropology and criminal justice from The George Washington University, and is a fellow of the National Press Foundation.

Connect:

email image

Latest from Kristen Monaco

Endo Break over a computer rendering of a man with illustrated body organs.

Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update

News and commentary from the endocrinology world

A photo of a woman鈥檚 forearm bound in a pink fiberglass cast.

Racial, Ethnic Differences in Fracture Risk for Postmenopausal Women Revealed

Fracture prevention strategies should be emphasized in other groups beyond white women

Illustration of a brain shaped maze.

MDMA Papers Retracted; School Bans Black Clothing; TikTok and Disordered Eating

News and commentary from the psychiatry world

Endo Break over a computer rendering of a man with illustrated body organs.

Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Lignins

News and commentary from the endocrinology world

A computer rendering of postsynaptic neuron receptors receiving emitted neurotransmitters from presynaptic neuron

Treatment of Tardive Dyskinesia

Until 2017, no FDA approved options existed for serious side effect of dopamine-blocking drugs

A close up photo of a blisterpack of pills.

Monitoring for Tardive Dyskinesia in Patients on Antipsychotics

Clinicians need to rely on prescribing practices that minimize risk of development, says expert

A photo of a woman opening the needle tip to an injection pen.

GLP-1 Agonists for Diabetes Tied to Lower Hyperkalemia Rates

Class was compared with DPP4-inhibitors

FDA APPROVED palopegteriparatide (Yorvipath) over a computer rendering of the thyroid gland.

FDA OKs Once-Daily Injection for Hypoparathyroidism

Palopegteriparatide will be the only drug targeting underlying cause of rare endocrine disorder

FDA ACTION midomafetamine (MDMA) over a photo of medication capsules.

FDA Rejects MDMA-Assisted Therapy for PTSD

Decision largely expected after agency advisors voted against psychedelic's safety and efficacy

FDA APPROVED iptacopan (Fabhalta) over a computer rendering of a transparent body with a kidney highlighted.

FDA OKs Complement Inhibitor for IgA Nephropathy

First-in-class iptacopan approved to reduce proteinuria in adults with rare progressive disease

鈥�

10

鈥�